SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research

被引：1
|
作者：
Guven, Deniz C. [1 ]
Sahin, Taha K. [2 ]
Akin, Serkan [1 ,3 ]
Uckun, Fatih M. [4 ,5 ]
机构：
[1] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Internal Med, Ankara, Turkey
[3] Hacettepe Univ, Inst Canc, Bone Marrow Transplantat Unit, Ankara, Turkey
[4] Ares Pharmaceut, Immunooncol Program, St Paul, MN 55110 USA
[5] Ares Pharmaceut, COVID 19 Task Force, St Paul, MN 55110 USA
来源：
ONCOLOGIST | 2022年 / 27卷 / 11期
关键词：
COVID-19; VACCINATION;
D O I：
10.1093/oncolo/oyac173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E917 / E918
页数：2
相关论文
共 50 条
  • [21] Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
    Tamariz-Amador, Luis-Esteban
    Battaglia, Anna Martina
    Maia, Catarina
    Zherniakova, Anastasiia
    Guerrero, Camila
    Zabaleta, Aintzane
    Burgos, Leire
    Botta, Cirino
    Fortuno, Maria-Antonia
    Grande, Carlos
    Manubens, Andrea
    Arguinano, Jose-Maria
    Gomez, Clara
    Perez-Persona, Ernesto
    Olazabal, Inigo
    Oiartzabal, Itziar
    Panizo, Carlos
    Prosper, Felipe
    San-Miguel, Jesus F.
    Rodriguez-Otero, Paula
    Martin-Sanchez, Esperanza
    Paiva, Bruno
    BLOOD CANCER JOURNAL, 2021, 11 (12)
  • [22] Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
    Luis-Esteban Tamariz-Amador
    Anna Martina Battaglia
    Catarina Maia
    Anastasiia Zherniakova
    Camila Guerrero
    Aintzane Zabaleta
    Leire Burgos
    Cirino Botta
    Maria-Antonia Fortuño
    Carlos Grande
    Andrea Manubens
    Jose-Maria Arguiñano
    Clara Gomez
    Ernesto Perez-Persona
    Iñigo Olazabal
    Itziar Oiartzabal
    Carlos Panizo
    Felipe Prosper
    Jesus F. San-Miguel
    Paula Rodriguez-Otero
    Esperanza Martín-Sánchez
    Bruno Paiva
    Blood Cancer Journal, 11
  • [23] Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis
    Rubio, Jose Luis Callejas
    Fernandez, Raquel Rios
    Fernandez, Javier De la Hera
    MEDICINA CLINICA, 2022, 158 (02): : 91 - 92
  • [24] Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series
    Perez-Catalan, Ignacio
    Gomez-Alfaro, Iris
    Garcia-Munoz, Sergio
    Roig-Marti, Celia
    Rodriguez-Lozano, Noelia
    Fabra-Juana, Sergio
    Esteve-Gimeno, Maria-Jose
    Gascon-Buj, Adriana
    Freiria-Alberte, Carmen
    Clavel-Pia, Juana
    Torres-Garcia, Miguel
    Reig-Valero, Roberto
    Ferrando-Piqueres, Raul
    Mateu-Campos, Lidon
    Uso-Blasco, Jorge
    Ramos-Rincon, Jose-Manuel
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [25] Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies
    Aiello, Tommaso Francesco
    Peyrony, Olivier
    Chumbita, Mariana
    Monzo, Patricia
    Lopera, Carlos
    Puerta-Alcalde, Pedro
    Magnano, Laura
    Fernandez-Aviles, Francesc
    Cuesta, Genoveva
    Tuset, Montse
    Mensa, Josep
    Esteve, Jordi
    Marcos, Maria Angeles
    Soriano, Alex
    Garcia-Vidal, Carolina
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (03)
  • [26] Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
    Fattizzo, Bruno
    Bortolotti, Marta
    Rampi, Nicolo
    Cavallaro, Francesca
    Giannotta, Juri Alessandro
    Bucelli, Cristina
    Cassin, Ramona
    Da Via, Matteo Claudio
    Galassi, Giulia
    Noto, Alessandro
    Pettine, Loredana
    Rossi, Francesca Gaia
    Sciume, Mariarita
    Ceriotti, Ferruccio
    Consonni, Dario
    Barcellini, Wilma
    Baldini, Luca
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis
    Abid, Muhammad Bilal
    Rubin, Micah
    Szabo, Aniko
    Longo, Walter
    Fenske, Timothy S.
    McCoy, Cole
    Lorge, Aaron
    Abedin, Sameem
    Souza, Anita
    Dhakal, Binod
    Shah, Nirav N.
    Hamadani, Mehdi
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 285 - 297
  • [28] SARS-CoV-2 vaccine safe for young patients
    Onuora S.
    Nature Reviews Rheumatology, 2022, 18 (10) : 552 - 552
  • [29] Outcomes and Risk Factors in Patients with Hematologic Malignancies Following Late-Stage SARS-CoV-2 Infection
    Wang, Lina
    Liu, Jiang
    Guo, Yafang
    Zhao, Meiling
    Zhang, Bozheng
    Zhang, Junyan
    Zhang, Ruijuan
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 5853 - 5865
  • [30] SARS-COV-2 infection in patients with hematological malignancies and transplants
    Herrera, Fabian
    Bues, Florencia
    Rojas, Rocio
    Temporiti, Elena
    Videla, Cristina
    Dupont, Juan
    Bonvehi, Pablo
    MEDICINA-BUENOS AIRES, 2021, 81 (03) : 396 - 400
12345